Thu0295 Low Immunogenicity in Patients With Giant Cell Arteritis Treated With Tocilizumab: 3-year Results From the Randomized Controlled Portion and Open-label Follow-up of a Phase 3 Trial
Year: 2020
Type: conference-abstract
Source: Annals of the Rheumatic Diseases
Authors: M. Bao, N.L. Mallalieu, J.H. Stone
Institutions: Genentech, Harvard University, Massachusetts General Hospital
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W3033736370